C[C@H]1NC(=O)[C@@]2(C)[C@@H](c3ccccc3)[C@H]3COc4ccccc4[C@H]3N2C1=O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?